相关实验视频
Updated: Sep 30, 2026

09:22
In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
Published on: January 2, 2015
19.1K
通过HIF3A介导的TXNIP异常激活促进了阿尔茨海默氏病的进展
Meng Xue1, Wuzhou Zheng2, Fang Li3
1Neurology Department, Yellow River Sanmenxia Hospital, Sanmenxia, Henan Province, China. xuemeng5200204@163.com.
Scientific reports
|March 11, 2026
概括
氧化应激在阿尔茨海默病 (AD) 中升高,特别是在星球细胞中. 天体细胞HIF3A通过上调TXNIP来驱动这种损伤,为AD提供了潜在的治疗标.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学是一种遗传学.
- 分子生物学分子生物学
背景情况:
- 氧化应激 (OS) 是阿尔茨海默病 (AD) 的关键特征,但其细胞特异性机制尚未完全理解.
- 调查细胞类型特定的OS对于理解AD病变发生至关重要.
研究的目的:
- 用单细胞RNA测序分析阿尔茨海默病中细胞类型特定的氧化应激特征.
- 确定AD中OS的关键基因和分子机制.
主要方法:
- 单细胞RNA测序 (scRNA-seq) 数据分析.
- 使用多个算法计算操作系统得分.
- 不同表达,路径丰富,PPI网络分析和机器学习 (ML) 方法.
- 批量和单细胞水平的验证,以及功能性测试.
主要成果:
- 在AD中,OS活性显著增加,细胞类型异质性显著.
- 星球细胞显示最高的OS活动,但在AD中相应减少.
- 鉴定出HIF3A是关键的OS相关基因,在星球细胞中高度表达.
- HIF3A对TXNIP进行上调,增加线粒体ROS,损害能量代谢,并恶化天体细胞系统.
结论:
- 天体细胞HIF3A在通过TXNIP调解AD中异常的OS反应方面发挥着关键作用.
- 针对星球细胞中的HIF3A-TXNIP通路可能提供一种治疗策略,以减轻AD中的氧化损伤.
相关概念视频
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...

